Corvus Pharmaceuticals
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CRVS and other ETFs, options, and stocks.About CRVS
Corvus Pharmaceuticals, Inc. engages in the development of product candidates for the treatment of cancer and immune-mediated and inflammatory diseases. Its product candidates include soquelitinib, an ITK inhibitor, ciforadenant, an adenosine A2A receptor antagonist, and mupadolimab, a B cell-activating anti-CD73 antibody.
CRVS Key Statistics
Stock Snapshot
With a market cap of 902.62M, Corvus Pharmaceuticals(CRVS) trades at $10.80. The stock has a price-to-earnings ratio of -17.39.
As of 2026-10-05, Corvus Pharmaceuticals(CRVS) stock has fluctuated between $10.45 and $10.90. The current price stands at $10.80, placing the stock +3.3% above today's low and -0.9% off the high.
The Corvus Pharmaceuticals(CRVS)'s current trading volume is 824.03K, compared to an average daily volume of 1.04M.
In the last year, Corvus Pharmaceuticals(CRVS) shares hit a 52-week high of $26.95 and a 52-week low of $6.39.
In the last year, Corvus Pharmaceuticals(CRVS) shares hit a 52-week high of $26.95 and a 52-week low of $6.39.
CRVS News
Corvus Pharmaceuticals (CRVS) announced that enrollment has begun in its Phase 1b clinical trial of soquelitinib for the treatment of patients with hidradenitis...
Analyst ratings
100%
of 8 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.